期刊文献+

阿戈美拉汀与氟西汀治疗抑郁症的对照研究 被引量:3

下载PDF
导出
摘要 目的比较阿戈美拉汀和氟西汀治疗抑郁症的疗效和安全性。方法 82例抑郁症患者,随机分为阿戈美拉汀组与氟西汀组,各41例。阿戈美拉汀组采用阿戈美拉汀治疗,氟西汀组采用氟西汀治疗。采用汉密尔顿抑郁量表(HAMD)、副反应量表(TESS)评定疗效和不良反应。结果两组HAMD评分及治疗总有效率比较差异无统计学意义(P>0.05);治疗第2、4、6周,阿戈美拉汀组TESS评分低于氟西汀组(P<0.05或0.01)。结论阿戈美拉汀抗抑郁效果确切,存在较少的不良反应,较氟西汀更为安全。
作者 柴森
出处 《中国现代药物应用》 2016年第11期216-217,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献6

  • 1Sartorius N, Baghai TC, Baldwin DS, et al.Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.Int J Neuropsychopharmacol, 2007, 10( Suppl 1):S1-$207.
  • 2Millan MJ. Multi-target strategies for the improved treatfnent of de pressive states: Conceptualfoundations and neuronal substrates, d rug discovery and therapeutic application.Pharmacol Ther, 2006, 110(2): 135-370.
  • 3Heun R, Ahokas A, Boyer P, et al.The efficacy of agomelatine in el derly patients with recurrent major depressive disorder', aplacebo- controlled study. J Clin Psychiatry, 2013,74(6):587-594.
  • 4戴雯姬,司天梅.阿戈美拉汀的药理机制及临床疗效[J].中国心理卫生杂志,2012,26(3):193-198. 被引量:54
  • 5Kasper S, Hajak G, Wulff K, et al. Effieaey of the novel antidepressant agomelatine on the circadian rest-activity cycle anddepressive and anxiety symptoms in patients with major depressive disorder: arandomized, double-blind comparison with sertraline. J Clin Psychiatry, 2010,71(2): 109-120.
  • 6Querasalva MA, Hajak G, Philip P, et al. Comparison of agomelatine and eseitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients.Int Clin Psyehopharmacol, 2011, 26(5):252-262.

二级参考文献35

  • 1Sartorius N,Baghai TC,Baldwin DS,et al.Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence[J]. Int J Neuropsychopharmacol,2007,10 (Suppl.1): S1-207.
  • 2Millan MJ.Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates,drug discovery and therapeutic application[J]. Pharmacol THer,2006,110(2): 135-370.
  • 3Souêtre E,Salvati E,Belugou JL,et al.Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality[J]. Psychiatry Res,1989,28(3): 263-278.
  • 4Duncan WC Jr.Circadian rhythms and the pharmacology of affective illness[J]. Pharmacol Ther,1996,71(3): 253-312.
  • 5Germain A,Kupfer DJ.Circadian rhythm disturbances in depression[J]. Hum Psychopharmacol,2008,23(7): 571-585.
  • 6Audinot V,Mailliet F,Lahaye-Brasseur C,et al.New selective ligands of human cloned melatonin MT1 and MT2 receptors[J]. Naunyn Schmiedebergs Arch Pharmacol,2003,367(6): 553-561.
  • 7Kasper S,Hamon M.Beyond the monoaminergic hypothesis: agomelatine,a new antidepressant with an innovative mechanism of action[J]. World J Biol Psychiatry,2009,10(2): 117-126.
  • 8de Bodinat C,Guardiola-Lemaitre B,Moca r E,et al.Agomelatine,the first melatonergic antidepressant: discovery,characterization and development[J]. Nat Rev Drug Discov,2010,9(8): 628-642.
  • 9Yous S,Andrieux J,Howell HE,et al.Novel naphthalenic ligands with high affinity for the melatonin receptor[J]. J Med Chem,1992,35(8): 1484-1486.
  • 10Kr uchi K,Cajochen C,M ri D,et al.Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature[J]. J Physiol,1997,272(4 Pt 2): R1178-R1188.

共引文献53

同被引文献34

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部